Income at the Malaria Consortium increased by £14m last year, up by about a third on the previous 12 months, the charity’s latest accounts show.
In its accounts for the year to 31 March 2017, published on the Companies House website yesterday, the charity, which works to treat and prevent the spread of malaria and other diseases, reported a total income of almost £55m, up from £40.9m in the previous year.
The accounts show that a large number of new grants and contracts have helped to account for the increase, meaning the charity registered a cash surplus of £16.4m over the year, compared with deficit of almost £4.7m the previous year.
New grants and contracts obtained by the charity include funding from the global pandemic organisation Unitaid, which has almost doubled its restricted and unrestricted spending with the charity from £12.2m to £24.1m, and new funding from the philanthropic foundation Good Ventures worth almost £4m.
The Global Fund partnership has also provided two sources of funding, worth £3.3m in Uganda – a new funding commitment – and £3.1m in Mozambique, a £2m increase on the previous year.
Unicef gave the charity £2.6m in funding, compared with £283,000 the previous year, the accounts show.
Expenditure at the Malaria Consortium also increased, from £41.2m to £50.8m in the most recent accounts.
The highest earner at the charity was paid between £160,000 and £169,999, the accounts show, with the chief executive receiving a salary of £115,513.
Last year, the Malaria Consortium was ranked as one of the world’s seven most effective charities by the US-based charity evaluator GiveWell.